COVID-19: lipid disruption is pushing the envelope

[1]  Patricia R S Rodrigues,et al.  The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses , 2022, Journal of Lipid Research.

[2]  C. Wheelock,et al.  Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages , 2022, Mucosal Immunology.

[3]  J. Casanova,et al.  Type I interferons and SARS-CoV-2: from cells to organisms , 2022, Current Opinion in Immunology.

[4]  J. Moreno-Navarrete,et al.  Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon , 2021, Computational and Structural Biotechnology Journal.

[5]  G. FitzGerald,et al.  The roles of lipids in SARS-CoV-2 viral replication and the host immune response , 2021, Journal of Lipid Research.

[6]  M. Landray,et al.  Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial , 2021, medRxiv.

[7]  T. Welte,et al.  Between inflammation and thrombosis: endothelial cells in COVID-19 , 2021, European Respiratory Journal.

[8]  K. Mann,et al.  Prothrombinase: the paradigm for membrane bound enzyme complexes; a memoir , 2021, Journal of Thrombosis and Thrombolysis.

[9]  G. FitzGerald,et al.  Bioactive lipids in antiviral immunity , 2021, Science.

[10]  A. M. Muñoz Martín,et al.  Thrombosis and Coagulopathy in COVID-19 , 2020, Current Problems in Cardiology.

[11]  A. Mulholland,et al.  Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein , 2020, Science.

[12]  Sasikanth Manne,et al.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications , 2020, Science.